BPC-157 for Musculoskeletal Injuries: Tendons, Fractures, and Soft Tissue A 2025 systematic review of 36 studies found BPC-157 improved functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injury models while consistently reducing inflammatory cytokines IL-1beta and TNF-alpha
These clinical studies indicate that a topical product containing GHK-Cu may be administered for 4-12 weeks to improve the appearance, texture, and health of the skin
Pawel MK, Kamachi T, Kumar M, Yoshizawa K
WARNINGS: Keep out of reach of children
GHK-Cu (copper peptide) is the star of the skin show
Sublingual peptides (tesamorelin, BPC-157, and others): These bypass some of the digestive breakdown by absorbing through the mouth lining